{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:44:11Z","timestamp":1793335451341,"version":"4.5.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level scientific and technological talents and innovation team Program of Yunnan Province","award":["202305AS350027"],"award-info":[{"award-number":["202305AS350027"]}]},{"name":"Key Research and development Project of Yunnan Province","award":["No.202103AC100004"],"award-info":[{"award-number":["No.202103AC100004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01577-3","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:19:36Z","timestamp":1741598376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management"],"prefix":"10.1007","volume":"25","author":[{"given":"Xitong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"4","key":"1577_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201706-1215OC","volume":"197","author":"P Douschan","year":"2018","unstructured":"Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, Olschewski H. Mild elevation of pulmonary arterial pressure as a predictor of mortality. Am J Respir Crit Care Med. 2018;197(4):509\u201316.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4 Suppl 1","key":"1577_CR2","first-page":"e1","volume":"24","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. G Ital Cardiol (Rome). 2023;24(4 Suppl 1):e1\u2013116.","journal-title":"G Ital Cardiol (Rome)"},{"issue":"2","key":"1577_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/ham.2005.6.147","volume":"6","author":"F Le\u00f3n-Velarde","year":"2005","unstructured":"Le\u00f3n-Velarde F, Maggiorini M, Reeves JT, Aldashev A, Asmus I, Bernardi L, Ge RL, Hackett P, Kobayashi T, Moore LG, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005;6(2):147\u201357.","journal-title":"High Alt Med Biol"},{"key":"1577_CR4","doi-asserted-by":"crossref","unstructured":"Zhang H, He Y, Cui C, Ouzhuluobu, Baimakangzhuo, Duojizhuoma, Dejiquzong, Bianba, Gonggalanzi, Pan Y et al: Cross-altitude analysis suggests a turning point at the elevation of 4,500 m for polycythemia prevalence in Tibetans. Am J Hematol 2017, 92(9):E552\u2013e554.","DOI":"10.1002\/ajh.24809"},{"issue":"1","key":"1577_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-018-0270-8","volume":"27","author":"A Iranmehr","year":"2019","unstructured":"Iranmehr A, Stobdan T, Zhou D, Poulsen O, Strohl KP, Aldashev A, Telenti A, Wong EHM, Kirkness EF, Venter JC, et al. Novel insight into the genetic basis of high-altitude pulmonary hypertension in Kyrgyz highlanders. Eur J Hum Genet. 2019;27(1):150\u20139.","journal-title":"Eur J Hum Genet"},{"issue":"111","key":"1577_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1183\/09059180.00011104","volume":"18","author":"XQ Xu","year":"2009","unstructured":"Xu XQ, Jing ZC. High-altitude pulmonary hypertension. Eur Respir Rev. 2009;18(111):13\u20137.","journal-title":"Eur Respir Rev"},{"issue":"10","key":"1577_CR7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1164\/rccm.200204-345OC","volume":"166","author":"AA Aldashev","year":"2002","unstructured":"Aldashev AA, Sarybaev AS, Sydykov AS, Kalmyrzaev BB, Kim EV, Mamanova LB, Maripov R, Kojonazarov BK, Mirrakhimov MM, Wilkins MR, et al. Characterization of high-altitude pulmonary hypertension in the Kyrgyz: association with angiotensin-converting enzyme genotype. Am J Respir Crit Care Med. 2002;166(10):1396\u2013402.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1577_CR8","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1152\/jappl.1991.70.5.2126","volume":"70","author":"SH Audi","year":"1991","unstructured":"Audi SH, Dawson CA, Rickaby DA, Linehan JH. Localization of the sites of pulmonary vasomotion by use of arterial and venous occlusion. J Appl Physiol. 1991;70(5):2126\u201336.","journal-title":"J Appl Physiol"},{"issue":"2","key":"1577_CR9","doi-asserted-by":"crossref","first-page":"190274","DOI":"10.1183\/13993003.02474-2019","volume":"56","author":"M Lichtblau","year":"2020","unstructured":"Lichtblau M, Saxer S, Furian M, Mayer L, Bader PR, Scheiwiller PM, Mademilov M, Sheraliev U, Tanner FC, Sooronbaev TM, et al. Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m. Eur Respir J. 2020;56(2):190274.","journal-title":"Eur Respir J"},{"issue":"1","key":"1577_CR10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1152\/jappl.1993.74.1.312","volume":"74","author":"BM Groves","year":"1993","unstructured":"Groves BM, Droma T, Sutton JR, McCullough RG, McCullough RE, Zhuang J, Rapmund G, Sun S, Janes C, Moore LG. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3658 m. J Appl Physiol. 1993;74(1):312\u20138.","journal-title":"J Appl Physiol"},{"issue":"8","key":"1577_CR11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/molbev\/mst093","volume":"30","author":"X Qi","year":"2013","unstructured":"Qi X, Cui C, Peng Y, Zhang X, Yang Z, Zhong H, Zhang H, Xiang K, Cao X, Wang Y, et al. Genetic evidence of paleolithic colonization and neolithic expansion of modern humans on the tibetan plateau. Mol Biol Evol. 2013;30(8):1761\u201378.","journal-title":"Mol Biol Evol"},{"issue":"5","key":"1577_CR12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/ars.2009.2862","volume":"12","author":"JR Desireddi","year":"2010","unstructured":"Desireddi JR, Farrow KN, Marks JD, Waypa GB, Schumacker PT. Hypoxia increases ROS signaling and cytosolic Ca(2+) in pulmonary artery smooth muscle cells of mouse lungs slices. Antioxid Redox Signal. 2010;12(5):595\u2013602.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1577_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","volume":"151","author":"KJ Dunham-Snary","year":"2017","unstructured":"Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151(1):181\u201392.","journal-title":"Chest"},{"issue":"6","key":"1577_CR14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pcad.2010.02.012","volume":"52","author":"F Le\u00f3n-Velarde","year":"2010","unstructured":"Le\u00f3n-Velarde F, Villafuerte FC, Richalet JP. Chronic mountain sickness and the heart. Prog Cardiovasc Dis. 2010;52(6):540\u20139.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"1577_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1378\/chest.11-0342","volume":"141","author":"SF Rimoldi","year":"2012","unstructured":"Rimoldi SF, Rexhaj E, Pratali L, Bailey DM, Hutter D, Faita F, Salinas Salm\u00f2n C, Villena M, Nicod P, Allemann Y, et al. Systemic vascular dysfunction in patients with chronic mountain sickness. Chest. 2012;141(1):139\u201346.","journal-title":"Chest"},{"issue":"2","key":"1577_CR16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1183\/09031936.00128706","volume":"30","author":"O Pak","year":"2007","unstructured":"Pak O, Aldashev A, Welsh D, Peacock A. The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J. 2007;30(2):364\u201372.","journal-title":"Eur Respir J"},{"issue":"2","key":"1577_CR17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/ham.2013.1016","volume":"14","author":"DJ Welsh","year":"2013","unstructured":"Welsh DJ, Peacock AJ. Cellular responses to hypoxia in the pulmonary circulation. High Alt Med Biol. 2013;14(2):111\u20136.","journal-title":"High Alt Med Biol"},{"issue":"2","key":"1577_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.RES.19.2.426","volume":"19","author":"M Kato","year":"1966","unstructured":"Kato M, Staub NC. Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res. 1966;19(2):426\u201340.","journal-title":"Circ Res"},{"issue":"25 Suppl","key":"1577_CR19","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","volume":"62","author":"A Vonk-Noordegraaf","year":"2013","unstructured":"Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62(25 Suppl):D22-33.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1577_CR20","volume":"7","author":"XR Zuo","year":"2012","unstructured":"Zuo XR, Wang Q, Cao Q, Yu YZ, Wang H, Bi LQ, Xie WP, Wang H. Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension. PLoS ONE. 2012;7(9): e44485.","journal-title":"PLoS ONE"},{"issue":"4","key":"1577_CR21","first-page":"391","volume":"31","author":"JJ Ryan","year":"2015","unstructured":"Ryan JJ, Huston J, Kutty S, Hatton ND, Bowman L, Tian L, Herr JE, Johri AM, Archer SL. Right ventricular adaptation and failure in pulmonary arterial hypertension. Can J Cardiol. 2015;31(4):391\u2013406.","journal-title":"Can J Cardiol"},{"issue":"1","key":"1577_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","volume":"115","author":"JJ Ryan","year":"2014","unstructured":"Ryan JJ, Archer SL. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res. 2014;115(1):176\u201388.","journal-title":"Circ Res"},{"issue":"23","key":"1577_CR23","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.3390\/ijms21238901","volume":"21","author":"JMM Kocken","year":"2020","unstructured":"Kocken JMM, da Costa Martins PA. Epigenetic regulation of pulmonary arterial hypertension-induced vascular and right ventricular remodeling: new opportunities? Int J Mol Sci. 2020;21(23):8901.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1577_CR24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89(9):1401\u201338.","journal-title":"Arch Toxicol"},{"issue":"1","key":"1577_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hfc.2011.08.010","volume":"8","author":"A Abbate","year":"2012","unstructured":"Abbate A, Narula J. Role of apoptosis in adverse ventricular remodeling. Heart Fail Clin. 2012;8(1):79\u201386.","journal-title":"Heart Fail Clin"},{"issue":"5","key":"1577_CR26","first-page":"2493","volume":"41","author":"F Sun","year":"2018","unstructured":"Sun F, Lu Z, Zhang Y, Geng S, Xu M, Xu L, Huang Y, Zhuang P, Zhang Y. Stage-dependent changes of \u03b22-adrenergic receptor signaling in right ventricular remodeling in monocrotaline-induced pulmonary arterial hypertension. Int J Mol Med. 2018;41(5):2493\u2013504.","journal-title":"Int J Mol Med"},{"key":"1577_CR27","unstructured":"Wagenvoort CA: The pathology of primary pulmonary hypertension. J Pathol 1970, 101(4):Pi."},{"issue":"1","key":"1577_CR28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.11-0793","volume":"141","author":"LC Price","year":"2012","unstructured":"Price LC, Wort SJ, Perros F, Dorfm\u00fcller P, Huertas A, Montani D, Cohen-Kaminsky S, Humbert M. Inflammation in pulmonary arterial hypertension. Chest. 2012;141(1):210\u201321.","journal-title":"Chest"},{"issue":"11","key":"1577_CR29","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/cells9112338","volume":"9","author":"Y Hu","year":"2020","unstructured":"Hu Y, Chi L, Kuebler WM, Goldenberg NM. Perivascular inflammation in pulmonary arterial hypertension. Cells. 2020;9(11):2338.","journal-title":"Cells"},{"key":"1577_CR30","unstructured":"X, Z, Z.Q, L, S. M: The pathogenesis of hypoxic pulmonary hypertension and the role of active components of Rhodiola rosea. Progress Physiol Sci 2021, 52(4):307\u2013310."},{"issue":"1","key":"1577_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/japplphysiol.00513.2014","volume":"119","author":"A Mishra","year":"2015","unstructured":"Mishra A, Mohammad G, Norboo T, Newman JH, Pasha MA. Lungs at high-altitude: genomic insights into hypoxic responses. J Appl Physiol. 2015;119(1):1\u201315.","journal-title":"J Appl Physiol"},{"issue":"1","key":"1577_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.118.10963","volume":"72","author":"WH Wu","year":"2018","unstructured":"Wu WH, Yuan P, Zhang SJ, Jiang X, Wu C, Li Y, Liu SF, Liu QQ, Li JH, Pudasaini B, et al. Impact of pituitary-gonadal axis hormones on pulmonary arterial hypertension in men. Hypertension. 2018;72(1):151\u20138.","journal-title":"Hypertension"},{"issue":"4","key":"1577_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0068-3","volume":"50","author":"Z Cai","year":"2018","unstructured":"Cai Z, Li J, Zhuang Q, Zhang X, Yuan A, Shen L, Kang K, Qu B, Tang Y, Pu J, et al. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-\u03b21 and IL-6\/STAT3 signaling pathways. Exp Mol Med. 2018;50(4):1\u201311.","journal-title":"Exp Mol Med"},{"issue":"4","key":"1577_CR34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2013.03.014","volume":"433","author":"L Luo","year":"2013","unstructured":"Luo L, Liu D, Tang C, Du J, Liu AD, Holmberg L, Jin H. Sulfur dioxide upregulates the inhibited endogenous hydrogen sulfide pathway in rats with pulmonary hypertension induced by high pulmonary blood flow. Biochem Biophys Res Commun. 2013;433(4):519\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1577_CR35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1183\/09031936.00044112","volume":"41","author":"P Yuan","year":"2013","unstructured":"Yuan P, Wu WH, Gao L, Zheng ZQ, Liu D, Mei HY, Zhang ZL, Jing ZC. Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J. 2013;41(5):1116\u201325.","journal-title":"Eur Respir J"},{"issue":"2","key":"1577_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/jcrt.JCRT_781_19","volume":"16","author":"N Shao","year":"2020","unstructured":"Shao N, Han Y, Song L, Song W. Clinical significance of hypoxia-inducible factor 1\u03b1, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma. J Cancer Res Ther. 2020;16(2):269\u201375.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"1577_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12881-019-0767-1","volume":"20","author":"F Cimmino","year":"2019","unstructured":"Cimmino F, Avitabile M, Lasorsa VA, Montella A, Pezone L, Cantalupo S, Visconte F, Corrias MV, Iolascon A, Capasso M. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia. BMC Med Genet. 2019;20(1):37.","journal-title":"BMC Med Genet"},{"issue":"7181","key":"1577_CR38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","volume":"451","author":"Z Arany","year":"2008","unstructured":"Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451(7181):1008\u201312.","journal-title":"Nature"},{"issue":"1","key":"1577_CR39","first-page":"139","volume":"54","author":"T Han","year":"2019","unstructured":"Han T, Yan J, Chen H, Ji Y, Chen J, Cui J, Shen W, Zou J. HIF-1\u03b1 contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3. Int J Oncol. 2019;54(1):139\u201351.","journal-title":"Int J Oncol"},{"issue":"4","key":"1577_CR40","first-page":"1582","volume":"51","author":"K Zhang","year":"2024","unstructured":"Zhang K, Basang ZZ, Ciren LB, et al. Study on the epigenetic mechanism of hypoxic adaptation in plateau animals. Chin Animal Husbandry Veterinary Med. 2024;51(4):1582\u201392.","journal-title":"Chin Animal Husbandry Veterinary Med"},{"key":"1577_CR41","unstructured":"Luo Y, J Lfy, Chen L et al.: Relationship between variation of VHL copy number in blood cells and susceptibility of plateau erythrocythemia. Med J Nat Defend Forces Southwest China 2011, 21(4):410\u2013412."},{"issue":"6","key":"1577_CR42","first-page":"755","volume":"23","author":"B Tang","year":"2009","unstructured":"Tang B, Qu Y, Mu D. Research progress of hypoxia inducible factor 1alpha in hypoxic-ischemic injury. Chin J Reparat Reconstr Surg. 2009;23(6):755\u20138.","journal-title":"Chin J Reparat Reconstr Surg"},{"issue":"6","key":"1577_CR43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1164\/rccm.200301-147OC","volume":"169","author":"R Bowers","year":"2004","unstructured":"Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF. Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med. 2004;169(6):764\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1577_CR44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","volume":"91","author":"RD Guzy","year":"2006","unstructured":"Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006;91(5):807\u201319.","journal-title":"Exp Physiol"},{"issue":"1","key":"1577_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/152702904322963690","volume":"5","author":"JA Jefferson","year":"2004","unstructured":"Jefferson JA, Simoni J, Escudero E, Hurtado ME, Swenson ER, Wesson DE, Schreiner GF, Schoene RB, Johnson RJ, Hurtado A. Increased oxidative stress following acute and chronic high altitude exposure. High Alt Med Biol. 2004;5(1):61\u20139.","journal-title":"High Alt Med Biol"},{"issue":"3","key":"1577_CR46","first-page":"288","volume":"28","author":"AC Montezano","year":"2012","unstructured":"Montezano AC, Touyz RM. Molecular mechanisms of hypertension\u2013reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol. 2012;28(3):288\u201395.","journal-title":"Can J Cardiol"},{"issue":"9","key":"1577_CR47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1113\/EP086040","volume":"102","author":"JPT Ward","year":"2017","unstructured":"Ward JPT. Physiological redox signalling and regulation of ion channels: implications for pulmonary hypertension. Exp Physiol. 2017;102(9):1078\u201382.","journal-title":"Exp Physiol"},{"issue":"9","key":"1577_CR48","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3181\/0712-RM-337","volume":"233","author":"S Sarada","year":"2008","unstructured":"Sarada S, Himadri P, Mishra C, Geetali P, Ram MS, Ilavazhagan G. Role of oxidative stress and NFkB in hypoxia-induced pulmonary edema. Exp Biol Med. 2008;233(9):1088\u201398.","journal-title":"Exp Biol Med"},{"key":"1577_CR49","doi-asserted-by":"crossref","first-page":"3795320","DOI":"10.1155\/2019\/3795320","volume":"2019","author":"A Smukowska-Gorynia","year":"2019","unstructured":"Smukowska-Gorynia A, Rzymski P, Marcinkowska J, Poniedzia\u0142ek B, Komosa A, Cieslewicz A, Slawek-Szmyt S, Janus M, Araszkiewicz A, Jankiewicz S, et al. Prognostic value of oxidative stress markers in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension. Oxid Med Cell Longev. 2019;2019:3795320.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"1577_CR50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1023\/A:1020238026534","volume":"133","author":"NL Irodova","year":"2002","unstructured":"Irodova NL, Lankin VZ, Konovalova GK, Kochetov AG, Chazova IE. Oxidative stress in patients with primary pulmonary hypertension. Bull Exp Biol Med. 2002;133(6):580\u20132.","journal-title":"Bull Exp Biol Med"},{"key":"1577_CR51","doi-asserted-by":"crossref","first-page":"6578578","DOI":"10.1155\/2016\/6578578","volume":"2016","author":"N L\u00fcneburg","year":"2016","unstructured":"L\u00fcneburg N, Siques P, Brito J, Arriaza K, Pena E, Klose H, Leon-Velarde F, B\u00f6ger RH. Long-term chronic intermittent hypobaric hypoxia in rats causes an imbalance in the asymmetric dimethylarginine\/nitric oxide pathway and ROS activity: a possible synergistic mechanism for altitude pulmonary hypertension? Pulm Med. 2016;2016:6578578.","journal-title":"Pulm Med"},{"issue":"3","key":"1577_CR52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jtcvs.2015.05.052","volume":"150","author":"Y Kishimoto","year":"2015","unstructured":"Kishimoto Y, Kato T, Ito M, Azuma Y, Fukasawa Y, Ohno K, Kojima S. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects. J Thorac Cardiovasc Surg. 2015;150(3):645-654.e643.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"15","key":"1577_CR53","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.15252\/embj.201696150","volume":"36","author":"BW Wong","year":"2017","unstructured":"Wong BW, Marsch E, Treps L, Baes M, Carmeliet P. Endothelial cell metabolism in health and disease: impact of hypoxia. Embo j. 2017;36(15):2187\u2013203.","journal-title":"Embo j"},{"issue":"4","key":"1577_CR54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.21037\/atm-22-259","volume":"10","author":"T Chai","year":"2022","unstructured":"Chai T, Qiu C, Xian Z, Lu Y, Zeng Y, Li J. A narrative review of research advances in hypoxic pulmonary hypertension. Ann Transl Med. 2022;10(4):230.","journal-title":"Ann Transl Med"},{"issue":"19","key":"1577_CR55","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.3390\/ijms221910701","volume":"22","author":"J Korbecki","year":"2021","unstructured":"Korbecki J, Simi\u0144ska D, G\u0105ssowska-Dobrowolska M, Listos J, Gutowska I, Chlubek D, Baranowska-Bosiacka I. Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-\u03baB activation: a review of the molecular mechanisms. Int J Mol Sci. 2021;22(19):10701.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1577_CR56","first-page":"855","volume":"16","author":"X Chen","year":"2019","unstructured":"Chen X, Yao JM, Fang X, Zhang C, Yang YS, Hu CP, Chen Q, Zhong GW. Hypoxia promotes pulmonary vascular remodeling via HIF-1\u03b1 to regulate mitochondrial dynamics. J Geriatr Cardiol. 2019;16(12):855\u201371.","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"1577_CR57","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-019-11500-6","volume":"10","author":"Y Luo","year":"2019","unstructured":"Luo Y, Teng X, Zhang L, Chen J, Liu Z, Chen X, Zhao S, Yang S, Feng J, Yan X. CD146-HIF-1\u03b1 hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nat Commun. 2019;10(1):3551.","journal-title":"Nat Commun"},{"issue":"2","key":"1577_CR58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.1002256","volume":"186","author":"SF Fitzpatrick","year":"2011","unstructured":"Fitzpatrick SF, Tambuwala MM, Bruning U, Schaible B, Scholz CC, Byrne A, O\u2019Connor A, Gallagher WM, Lenihan CR, Garvey JF, et al. An intact canonical NF-\u03baB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol. 2011;186(2):1091\u20136.","journal-title":"J Immunol"},{"issue":"3","key":"1577_CR59","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ijms21031034","volume":"21","author":"T Kammerer","year":"2020","unstructured":"Kammerer T, Faihs V, Hulde N, Stangl M, Brettner F, Rehm M, Horstmann M, Kr\u00f6pfl J, Spengler C, Kreth S, Sch\u00e4fer S. Hypoxic-inflammatory responses under acute hypoxia: In Vitro experiments and prospective observational expedition trial. Int J Mol Sci. 2020;21(3):1034.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1577_CR60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/2045893217705878","volume":"7","author":"K Schlosser","year":"2017","unstructured":"Schlosser K, Taha M, Deng Y, Jiang B, McIntyre LA, Mei SH, Stewart DJ. Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients. Pulm Circ. 2017;7(2):476\u201385.","journal-title":"Pulm Circ"},{"issue":"2","key":"1577_CR61","first-page":"275","volume":"144","author":"RM Tuder","year":"1994","unstructured":"Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol. 1994;144(2):275\u201385.","journal-title":"Am J Pathol"},{"issue":"6","key":"1577_CR62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.4049\/jimmunol.1900239","volume":"204","author":"YA Yu","year":"2020","unstructured":"Yu YA, Malakhau Y, Yu CA, Phelan SJ, Cumming RI, Kan MJ, Mao L, Rajagopal S, Piantadosi CA, Gunn MD. Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension. J Immunol. 2020;204(6):1474\u201385.","journal-title":"J Immunol"},{"issue":"1","key":"1577_CR63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165\u201375.","journal-title":"Circ Res"},{"key":"1577_CR64","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1038\/ncomms14079","volume":"8","author":"LA Hurst","year":"2017","unstructured":"Hurst LA, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, et al. TNF\u03b1 drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. Nat Commun. 2017;8:14079.","journal-title":"Nat Commun"},{"issue":"1","key":"1577_CR65","doi-asserted-by":"crossref","first-page":"L39","DOI":"10.1152\/ajplung.2001.280.1.L39","volume":"280","author":"M Fujita","year":"2001","unstructured":"Fujita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, Mason RJ. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001;280(1):L39-49.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"1577_CR66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/biomedicines10010170","volume":"10","author":"L Ho","year":"2022","unstructured":"Ho L, Hossen N, Nguyen T, Vo A, Ahsan F. Epigenetic mechanisms as emerging therapeutic targets and microfluidic chips application in pulmonary arterial hypertension. Biomedicines. 2022;10(1):170.","journal-title":"Biomedicines"},{"issue":"1","key":"1577_CR67","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"KB Lane","year":"2000","unstructured":"Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet. 2000;26(1):81\u20134.","journal-title":"Nat Genet"},{"issue":"3","key":"1577_CR68","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","volume":"67","author":"Z Deng","year":"2000","unstructured":"Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67(3):737\u201344.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1577_CR69","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2003.11890","volume":"59","author":"A Chaouat","year":"2004","unstructured":"Chaouat A, Coulet F, Favre C, Simonneau G, Weitzenblum E, Soubrier F, Humbert M. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax. 2004;59(5):446\u20138.","journal-title":"Thorax"},{"issue":"12","key":"1577_CR70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jmg.40.12.865","volume":"40","author":"RE Harrison","year":"2003","unstructured":"Harrison RE, Flanagan JA, Sankelo M, Abdalla SA, Rowell J, Machado RD, Elliott CG, Robbins IM, Olschewski H, McLaughlin V, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet. 2003;40(12):865\u201371.","journal-title":"J Med Genet"},{"issue":"24","key":"1577_CR71","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.3390\/jcm10245761","volume":"10","author":"J Hannemann","year":"2021","unstructured":"Hannemann J, Siques P, Schmidt-Hutten L, Zummack J, Brito J, B\u00f6ger R. Association of genes of the NO pathway with altitude disease and hypoxic pulmonary hypertension. J Clin Med. 2021;10(24):5761.","journal-title":"J Clin Med"},{"issue":"Pt 23","key":"1577_CR72","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1113\/jphysiol.2010.194704","volume":"588","author":"DM Bailey","year":"2010","unstructured":"Bailey DM, Dehnert C, Luks AM, Menold E, Castell C, Schendler G, Faoro V, Gutowski M, Evans KA, Taudorf S, et al. High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J Physiol. 2010;588(Pt 23):4837\u201347.","journal-title":"J Physiol"},{"key":"1577_CR73","unstructured":"RL. LCMLG: HIF-1 regulates hypoxiainduced pulmonary hypertension. Progress Physiol Sci 2018, 49(6):423\u2013427."},{"issue":"3","key":"1577_CR74","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.ijcard.2013.07.129","volume":"168","author":"A Maripov","year":"2013","unstructured":"Maripov A, Mamazhakypov A, Karagulova G, Sydykov A, Sarybaev A. High altitude pulmonary hypertension with severe right ventricular dysfunction. Int J Cardiol. 2013;168(3):e89-90.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1577_CR75","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/ijerph18041692","volume":"18","author":"A Sydykov","year":"2021","unstructured":"Sydykov A, Mamazhakypov A, Maripov A, Kosanovic D, Weissmann N, Ghofrani HA, Sarybaev AS, Schermuly RT. Pulmonary hypertension in acute and chronic high altitude maladaptation disorders. Int J Environ Res Public Health. 2021;18(4):1692.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"1577_CR76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/ham.2019.0143","volume":"21","author":"X Pu","year":"2020","unstructured":"Pu X, Lin X, Duan X, Wang J, Shang J, Yun H, Chen Z. Oxidative and endoplasmic reticulum stress responses to chronic high-altitude exposure during the development of high-altitude pulmonary hypertension. High Alt Med Biol. 2020;21(4):378\u201387.","journal-title":"High Alt Med Biol"},{"key":"1577_CR77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1874192401610010019","volume":"10","author":"AE Mirrakhimov","year":"2016","unstructured":"Mirrakhimov AE, Strohl KP. High-altitude pulmonary hypertension: an update on disease pathogenesis and management. Open Cardiovasc Med J. 2016;10:19\u201327.","journal-title":"Open Cardiovasc Med J"},{"issue":"4","key":"1577_CR78","first-page":"500","volume":"91","author":"LE Santos-Mart\u00ednez","year":"2021","unstructured":"Santos-Mart\u00ednez LE, G\u00f3mez-Tejada RA, Murillo-Jauregui CX, Hoyos-Paladines RA, Poyares-Jardim CV, Orozco-Levi M. Chronic exposure to altitude. Clinical characteristics and diagnosis. Arch Cardiol Mex. 2021;91(4):500\u20137.","journal-title":"Arch Cardiol Mex"},{"issue":"1","key":"1577_CR79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/mrm.24894","volume":"72","author":"JF Schmidt","year":"2014","unstructured":"Schmidt JF, Wissmann L, Manka R, Kozerke S. Iterative k-t principal component analysis with nonrigid motion correction for dynamic three-dimensional cardiac perfusion imaging. Magn Reson Med. 2014;72(1):68\u201379.","journal-title":"Magn Reson Med"},{"key":"1577_CR80","unstructured":"Group. ISoHAMCADE: Qinghai diagmostic criteria for chronic mountain sickness (CMS). J Qinghai Med College 2005, 26(01): 3\u20135."},{"issue":"1","key":"1577_CR81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","volume":"90","author":"F Grothues","year":"2002","unstructured":"Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29\u201334.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1577_CR82","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1148\/radiol.2343040151","volume":"234","author":"RJ Roeleveld","year":"2005","unstructured":"Roeleveld RJ, Marcus JT, Faes TJ, Gan TJ, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology. 2005;234(3):710\u20137.","journal-title":"Radiology"},{"issue":"11","key":"1577_CR83","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.amjcard.2008.01.055","volume":"101","author":"KM Chin","year":"2008","unstructured":"Chin KM, Kingman M, de Lemos JA, Warner JJ, Reimold S, Peshock R, Torres F. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol. 2008;101(11):1669\u201372.","journal-title":"Am J Cardiol"},{"key":"1577_CR84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2007.01479.x","volume":"156","author":"MJ Hegewald","year":"2007","unstructured":"Hegewald MJ, Markewitz B, Elliott CG. Pulmonary hypertension: clinical manifestations, classification and diagnosis. Int J Clin Pract Suppl. 2007;156:5\u201314.","journal-title":"Int J Clin Pract Suppl"},{"issue":"4","key":"1577_CR85","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for european paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u201375.","journal-title":"Eur Respir J"},{"key":"1577_CR86","doi-asserted-by":"crossref","unstructured":"Zeng Y, Yu Q, Maimaitiaili N, Li B, Liu P, Hou Y, Mima, Cirenguojie, Sumit G, Dejizhuoga et al: Clinical and predictive value of computed tomography angiography in high-altitude pulmonary hypertension. JACC Asia 2022, 2(7):803\u2013815.","DOI":"10.1016\/j.jacasi.2022.09.014"},{"issue":"1","key":"1577_CR87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1378\/chest.12-1246","volume":"144","author":"V Foris","year":"2013","unstructured":"Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H. Biomarkers in pulmonary hypertension: what do we know? Chest. 2013;144(1):274\u201383.","journal-title":"Chest"},{"key":"1577_CR88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fphys.2019.00054","volume":"10","author":"D Kosanovic","year":"2019","unstructured":"Kosanovic D, Platzek SM, Petrovic A, Sydykov A, Maripov A, Mamazhakypov A, Sartmyrzaeva M, Muratali Uulu K, Cholponbaeva M, Toktosunova A, et al. Circulating apoptotic signals during acute and chronic exposure to high altitude in Kyrgyz population. Front Physiol. 2019;10:54.","journal-title":"Front Physiol"},{"issue":"11","key":"1577_CR89","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698\u2013717.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1577_CR90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/BJ20070629","volume":"409","author":"A Weidemann","year":"2008","unstructured":"Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, Eckardt KU, Warnecke C. Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J. 2008;409(1):233\u201342.","journal-title":"Biochem J"},{"issue":"2","key":"1577_CR91","doi-asserted-by":"crossref","first-page":"e21212","DOI":"10.1096\/fj.202000533RR","volume":"35","author":"Q Lyu","year":"2021","unstructured":"Lyu Q, Bai Y, Cheng J, Liu H, Li S, Yang J, Wang Z, Ma Y, Jiang M, Dong D, et al. Intermittent short-duration reoxygenation protects against simulated high altitude-induced pulmonary hypertension in rats. Faseb j. 2021;35(2):e21212.","journal-title":"Faseb j"},{"issue":"4","key":"1577_CR92","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/eurheartj\/ehad789","volume":"45","author":"SR Schneider","year":"2024","unstructured":"Schneider SR, M\u00fcller J, Bauer M, Mayer L, L\u00fc\u00f6nd L, Ulrich T, Furian M, Forrer A, Carta A, Schwarz EI, et al. Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy. Eur Heart J. 2024;45(4):309\u201311.","journal-title":"Eur Heart J"},{"issue":"4 Suppl","key":"1577_CR93","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.wem.2014.06.017","volume":"25","author":"AM Luks","year":"2014","unstructured":"Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, Schoene RB, Zafren K, Hackett PH. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ Med. 2014;25(4 Suppl):S4-14.","journal-title":"Wilderness Environ Med"},{"issue":"6","key":"1577_CR94","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/ers.09.51","volume":"3","author":"JO Stream","year":"2009","unstructured":"Stream JO, Luks AM, Grissom CK. Lung disease at high altitude. Expert Rev Respir Med. 2009;3(6):635\u201350.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"1577_CR95","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/13880209.2020.1804407","volume":"58","author":"T Wang","year":"2020","unstructured":"Wang T, Hou J, Xiao W, Zhang Y, Zhou L, Yuan L, Yin X, Chen X, Hu Y. Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension. Pharmac Biol. 2020;58(1):815\u201327.","journal-title":"Pharmac Biol"},{"key":"1577_CR96","doi-asserted-by":"crossref","first-page":"j5492","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.","journal-title":"BMJ"},{"issue":"5","key":"1577_CR97","first-page":"e65","volume":"28","author":"SG Raja","year":"2010","unstructured":"Raja SG. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview. Cardiovasc Ther. 2010;28(5):e65-71.","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"1577_CR98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/ham.2011.1107","volume":"13","author":"B Kojonazarov","year":"2012","unstructured":"Kojonazarov B, Isakova J, Imanov B, Sovkhozova N, Sooronbaev T, Ishizaki T, Aldashev AA. Bosentan reduces pulmonary artery pressure in high altitude residents. High Alt Med Biol. 2012;13(3):217\u201323.","journal-title":"High Alt Med Biol"},{"key":"1577_CR99","unstructured":"Wang JX, Zhang YS, HL. L. The therapeutic effect of Tracleer on high altitude pulmonary edema. Progress Mod Biomed 2009; 9(4): 693\u2013695."},{"issue":"4","key":"1577_CR100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000087541.15600.2B","volume":"93","author":"SD Rybalkin","year":"2003","unstructured":"Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res. 2003;93(4):280\u201391.","journal-title":"Circ Res"},{"issue":"8","key":"1577_CR101","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thx.2005.041954","volume":"60","author":"AA Aldashev","year":"2005","unstructured":"Aldashev AA, Kojonazarov BK, Amatov TA, Sooronbaev TM, Mirrakhimov MM, Morrell NW, Wharton J, Wilkins MR. Phosphodiesterase type 5 and high altitude pulmonary hypertension. Thorax. 2005;60(8):683\u20137.","journal-title":"Thorax"},{"issue":"5579","key":"1577_CR102","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/263663a0","volume":"263","author":"S Moncada","year":"1976","unstructured":"Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263(5579):663\u20135.","journal-title":"Nature"},{"issue":"7","key":"1577_CR103","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","volume":"112","author":"LJ Rubin","year":"1990","unstructured":"Rubin LJ, Mendoza J, Hood M, McGoon M, Barst R, Williams WB, Diehl JH, Crow J, Long W. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol) results of a randomized trial. Ann Int Med. 1990;112(7):485\u201391.","journal-title":"Ann. Int. Med."},{"issue":"6","key":"1577_CR104","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","volume":"159","author":"RM Tuder","year":"1999","unstructured":"Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999;159(6):1925\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1577_CR105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","volume":"12","author":"ER Swenson","year":"1998","unstructured":"Swenson ER. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J. 1998;12(6):1242\u20137.","journal-title":"Eur Respir J"},{"issue":"11","key":"1577_CR106","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200505-807OC","volume":"172","author":"JP Richalet","year":"2005","unstructured":"Richalet JP, Rivera M, Bouchet P, Chirinos E, Onnen I, Petitjean O, Bienvenu A, Lasne F, Moutereau S, Le\u00f3n-Velarde F. Acetazolamide: a treatment for chronic mountain sickness. Am J Respir Crit Care Med. 2005;172(11):1427\u201333.","journal-title":"Am J Respir Crit Care Med"},{"key":"1577_CR107","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2017.10.001","volume":"336","author":"C Veith","year":"2017","unstructured":"Veith C, Drent M, Bast A, van Schooten FJ, Boots AW. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Toxicol Appl Pharmacol. 2017;336:40\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"1577_CR108","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.00095211","volume":"39","author":"B Kojonazarov","year":"2012","unstructured":"Kojonazarov B, Myrzaakhmatova A, Sooronbaev T, Ishizaki T, Aldashev A. Effects of fasudil in patients with high-altitude pulmonary hypertension. Eur Respir J. 2012;39(2):496\u20138.","journal-title":"Eur Respir J"},{"issue":"13","key":"1577_CR109","first-page":"4540","volume":"25","author":"Y Nijiati","year":"2021","unstructured":"Nijiati Y, Maimaitiyiming D, Yang T, Li H, Aikemu A. Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora. Eur Rev Med Pharmacol Sci. 2021;25(13):4540\u201353.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"1577_CR110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","volume":"99","author":"KR Stenmark","year":"2006","unstructured":"Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99(7):675\u201391.","journal-title":"Circ Res"},{"issue":"1","key":"1577_CR111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bph.15144","volume":"178","author":"M Gassmann","year":"2021","unstructured":"Gassmann M, Cowburn A, Gu H, Li J, Rodriguez M, Babicheva A, Jain PP, Xiong M, Gassmann NN, Yuan JX, et al. Hypoxia-induced pulmonary hypertension-utilizing experiments of nature. Br J Pharmacol. 2021;178(1):121\u201331.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1577_CR112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ame2.12220","volume":"5","author":"XH Wu","year":"2022","unstructured":"Wu XH, Ma JL, Ding D, Ma YJ, Wei YP, Jing ZC. Experimental animal models of pulmonary hypertension: development and challenges. Animal Model Exp Med. 2022;5(3):207\u201316.","journal-title":"Animal Model Exp Med"},{"issue":"6","key":"1577_CR113","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","volume":"297","author":"KR Stenmark","year":"2009","unstructured":"Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297(6):L1013-1032.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"1577_CR114","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/biom12060796","volume":"12","author":"L Deng","year":"2022","unstructured":"Deng L, Han X, Wang Z, Nie X, Bian J. The landscape of noncoding RNA in pulmonary hypertension. Biomolecules. 2022;12(6):796.","journal-title":"Biomolecules"},{"key":"1577_CR115","first-page":"6058784","volume":"2018","author":"T Yi","year":"2018","unstructured":"Yi T, Wang J, Zhu K, Tang Y, Huang S, Shui X, Ding Y, Chen C, Lei W. Aryl hydrocarbon receptor: a new player of pathogenesis and therapy in cardiovascular diseases. Biomed Res Int. 2018;2018:6058784.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1577_CR116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18585\/inabj.v14i1.1724","volume":"14","author":"D Nugrahaningsih","year":"2022","unstructured":"Nugrahaningsih D, Purnomo E, Wasityastuti W, Martien R. BMPR2 editing in fibroblast NIH3T3 using CRISPR\/Cas9 affecting BMPR2 mRNA expression and proliferation. Indones Biomed J. 2022;14(1):45\u201351.","journal-title":"Indones Biomed J"},{"key":"1577_CR117","doi-asserted-by":"crossref","unstructured":"Liu B, Peng Y, Yi D, Machireddy N, Dong D, Ramirez K, Dai J, Vanderpool R, Zhu MM, Dai Z et al: Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension. Eur Respir J 2022, 60(6).","DOI":"10.1183\/13993003.02643-2021"},{"issue":"3","key":"1577_CR118","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/ijms22031179","volume":"22","author":"N Rai","year":"2021","unstructured":"Rai N, Shihan M, Seeger W, Schermuly RT, Novoyatleva T. Genetic delivery and gene therapy in pulmonary hypertension. Int J Mol Sci. 2021;22(3):1179.","journal-title":"Int J Mol Sci"},{"key":"1577_CR119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pharmthera.2017.02.036","volume":"175","author":"G Zhang","year":"2017","unstructured":"Zhang G, Nebert DW. Personalized medicine: genetic risk prediction of drug response. Pharmacol Ther. 2017;175:75\u201390.","journal-title":"Pharmacol Ther"},{"key":"1577_CR120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fspor.2020.00106","volume":"2","author":"AE Koivisto-M\u00f8rk","year":"2020","unstructured":"Koivisto-M\u00f8rk AE, Paur I, Paulsen G, Garthe I, Raastad T, Bastani NE, Blomhoff R, B\u00f8hn SK. Dietary adjustments to altitude training in elite endurance athletes; impact of a randomized clinical trial with antioxidant-rich foods. Front Sports Act Living. 2020;2:106.","journal-title":"Front Sports Act Living"},{"issue":"Suppl 2","key":"1577_CR121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40279-019-01159-w","volume":"49","author":"T Stellingwerff","year":"2019","unstructured":"Stellingwerff T, Peeling P, Garvican-Lewis LA, Hall R, Koivisto AE, Heikura IA, Burke LM. Nutrition and altitude: strategies to enhance adaptation, improve performance and maintain health: a narrative review. Sports Med. 2019;49(Suppl 2):169\u201384.","journal-title":"Sports Med"},{"issue":"22","key":"1577_CR122","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3390\/molecules27228102","volume":"27","author":"Y Guo","year":"2022","unstructured":"Guo Y, Yong S, Xu Y, Hu Y, Li J, Long Q, Wang X, Gu C, Miao Z. Integrative analysis of proteomics and metabolism reveals the potential roles of arachidonic acid metabolism in hypoxia response in mouse spleen. Molecules. 2022;27(22):8102.","journal-title":"Molecules"},{"issue":"4","key":"1577_CR123","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/metabo9040076","volume":"9","author":"FR Pinu","year":"2019","unstructured":"Pinu FR, Beale DJ, Paten AM, Kouremenos K, Swarup S, Schirra HJ, Wishart D. Systems biology and multi-omics integration: viewpoints from the metabolomics research community. Metabolites. 2019;9(4):76.","journal-title":"Metabolites"},{"key":"1577_CR124","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.896818","volume":"13","author":"AK Yadav","year":"2022","unstructured":"Yadav AK, Banerjee SK, Das B, Chaudhary K. Editorial: systems biology and omics approaches for understanding complex disease biology. Front Genet. 2022;13: 896818.","journal-title":"Front Genet"},{"key":"1577_CR125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-pharmtox-010919-023324","volume":"60","author":"H Zhu","year":"2020","unstructured":"Zhu H. Big data and artificial intelligence modeling for drug discovery. Annu Rev Pharmacol Toxicol. 2020;60:573\u201389.","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01577-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:45:23Z","timestamp":1764917123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01577-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01577-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"79"}}